BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 6203232)

  • 21. [Significance of some immunological changes in acute glomerulonephritis].
    Gluhovschi G; Galea O; Sabo I; Klinda C; Arcan P; Schiller A; Romoşan I
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1983; 35(1):75-86. PubMed ID: 6137049
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of the B cell superantigen protein A from S. aureus on the early lupus disease of (NZBxNZW) F1 mice.
    Viau M; Zouali M
    Mol Immunol; 2005 May; 42(7):849-55. PubMed ID: 15829273
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Immunopathogenesis of autoimmune diseases].
    Yoshiki T
    Hokkaido Igaku Zasshi; 1984 Jul; 59(4):385-9. PubMed ID: 6092248
    [No Abstract]   [Full Text] [Related]  

  • 24. The etiopathogenesis of systemic lupus erythematosus.
    Quimby FW; Schwartz RS
    Pathobiol Annu; 1978; 8():35-59. PubMed ID: 214738
    [No Abstract]   [Full Text] [Related]  

  • 25. [The thymus gland and autoimmune diseases].
    Klug H
    Z Gesamte Inn Med; 1973 Aug; 28(15):441-50. PubMed ID: 4587798
    [No Abstract]   [Full Text] [Related]  

  • 26. [T- and B-lymphocyte populations in systemic lupus erythematosus and glomerulonephritis].
    Shilov EM; Traianova TG; Gordovskaia NB; Speranskiĭ AI
    Urol Nefrol (Mosk); 1979; (4):13-8. PubMed ID: 314191
    [No Abstract]   [Full Text] [Related]  

  • 27. Rheumatology Rounds at the Hospital for Special Surgery. Aspects of systemic lupus erythematosus: consideration of viral and genetic factors, and remarks on therapy.
    Christian CL; Mellors RC; Lightfoot RW; Block SR
    Am J Med Sci; 1975; 270(3):515-22. PubMed ID: 174427
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autoimmunity following neonatal tolerance to alloantigens: role of donor I-A and I-E molecules.
    Kramar G; Schurmans S; Berney M; Izui S; del Giudice G; Lambert PH
    J Autoimmun; 1995 Apr; 8(2):177-92. PubMed ID: 7612147
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The potential role of immunoregulatory disturbance in the pathogenesis of systemic lupus erythematosus.
    Bell DA
    J Rheumatol; 1981; 8(2):340-4. PubMed ID: 6971937
    [No Abstract]   [Full Text] [Related]  

  • 30. Autoimmunity and lymphoid malignancy in New Zealand black mice.
    Talal N
    Prog Clin Immunol; 1974; 2():101-20. PubMed ID: 4141778
    [No Abstract]   [Full Text] [Related]  

  • 31. [Systemic lupus erythematosus: disease or syndrome?].
    Font J; Cardellach F
    Med Clin (Barc); 1985 Apr; 84(16):657-9. PubMed ID: 3875769
    [No Abstract]   [Full Text] [Related]  

  • 32. Pathogenic autoantibodies.
    Bach JF
    Contrib Microbiol Immunol; 1989; 11():263-88. PubMed ID: 2684511
    [No Abstract]   [Full Text] [Related]  

  • 33. [Immunologic bases of glomerular nephropathy].
    Humair L
    Helv Med Acta Suppl; 1972; 52():1-75. PubMed ID: 4115338
    [No Abstract]   [Full Text] [Related]  

  • 34. FcgammaRIIB deficiency with Fas mutation is sufficient for the development of systemic autoimmune disease.
    Yajima K; Nakamura A; Sugahara A; Takai T
    Eur J Immunol; 2003 Apr; 33(4):1020-9. PubMed ID: 12672068
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systemic lupus erythematosus-related autoantibody production in mice is determined by bone marrow-derived cells.
    Levite M; Zinger H; Mozes E; Reisner Y
    Bone Marrow Transplant; 1993 Sep; 12(3):179-83. PubMed ID: 8241973
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pathogenetic aspects of Schönlein-Henoch disease].
    Mishkova R; Kudeva K; Kis'ova K; Deliĭski M
    Vutr Boles; 1986; 25(2):1-5. PubMed ID: 2940752
    [No Abstract]   [Full Text] [Related]  

  • 37. Long term administration of cyclophosphamide in MRL/1 mice. I. The effects on the development of immunological abnormalities and lupus nephritis.
    Shiraki M; Fujiwara M; Tomura S
    Clin Exp Immunol; 1984 Feb; 55(2):333-9. PubMed ID: 6607792
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Murine models of lupus erythematosus disseminatus].
    Youinou P
    Ann Med Interne (Paris); 1989; 140(8):721-8. PubMed ID: 2534265
    [No Abstract]   [Full Text] [Related]  

  • 39. Etiologic agents of immune-deposit disease.
    Roy LP; Fish AJ; Michael AF; Vernier RL
    Prog Clin Immunol; 1972; 1():1-22. PubMed ID: 4142093
    [No Abstract]   [Full Text] [Related]  

  • 40. Immune complexes--pathogenetic factors of autoimmune systemic lupus erythematosus.
    Wollina U
    Allerg Immunol (Leipz); 1984; 30(1):3-13. PubMed ID: 6233860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.